Dennis Matheis's most recent trade in Lucid Diagnostics Inc was a trade of 100,000 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on Aug. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lucid Diagnostics Inc | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 20 Aug 2025 | 100,000 | 665,443 | - | 1.0 | 101,840 | Common Stock |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 20 May 2025 | 187,098 | 187,098 | - | 1.3 | 242,292 | Common Stock |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 20 May 2025 | 187,098 | 402,541 | - | 1.3 | 242,292 | Common Stock |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 20 May 2025 | 129,684 | 316,782 | - | 1.3 | 171,520 | Common Stock |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 20 May 2025 | 129,684 | 532,225 | - | 1.3 | 171,520 | Common Stock |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 20 May 2025 | 33,218 | 350,000 | - | 1.3 | 43,795 | Common Stock |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 20 May 2025 | 33,218 | 565,443 | - | 1.3 | 43,795 | Common Stock |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 162,725 | - | 0 | Common Stock | |
| Lucid Diagnostics Inc | Dennis Matheis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 241,500 | 241,500 | - | - | Employee stock option (right to buy) | |
| DarioHealth Corp | Dennis Matheis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 70,000 | 152,620 (6%) | 3% | 0 | Common Stock | |
| DarioHealth Corp | Dennis Matheis | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 May 2023 | 50 | 50 | - | - | Series B-2 Preferred Stock | |
| DarioHealth Corp | Dennis Matheis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 17,620 | 82,620 | - | 0 | Restricted Stock Units |